long-acting injectable cabotegravir for prep: understanding results of hptn 083 & 084 & advocacy
Published 3 years ago • 383 plays • Length 1:37:35Download video MP4
Download video MP3
Similar videos
-
18:33
long-acting injectable cabotegravir: the future of hiv prep?
-
59:52
hptn 084 primary study results - friday, 13 november 2020
-
39:09
long-acting im cabotegravir (cab) for hiv pre-exposure prophylaxis: dr. landovitz discusses hptn 083
-
1:17:11
hptn 083 preliminary study results webinar
-
59:20
"long-acting injectable cabotegravir for hivpre-exposure prophylaxis"
-
1:48
long-acting cabotegravir and the potential benefits of injectables
-
0:58
the hptn 083 parallel study and injectable prep development package
-
38:46
hptn 083 study update press briefing may 18 2020
-
1:45
hptn 084 and enhancing the prep toolbox for women
-
58:53
topics in research ethics: post trial responsibilities & access to injectable cabotegravir for prep
-
1:02:44
long-acting injectable cabotegravir for hiv prep: what we know and what we need to know
-
20:47
mini lecture series: long-acting, injectable cabotegravir-rilpivirine (cab-rpv)
-
12:53
uthsa hiv echo 3/25/22- long acting injectable cabotegravir for prep
-
44:51
long-acting hiv pre-exposure prophylaxis
-
1:01:55
icap grand rounds — long-acting injectable cabotegravir for hiv prevention: promises and pitfalls
-
19:01
hiv testing in prepinjectable cabotegravir
-
22:05
long-acting cabotegravir / rilpivirine for individuals with detectable viral loads
-
56:54
"did you know there is a new prep?”: hptn 083 los angeles community local engagement event
-
20:34
long-acting injectable prep and hiv treatment podcast